Intelligent Bio Solutions Inc. (INBS)

2.3400 -0.0200 (-0.85%) At close: 03:59PM EDT

Intelligent Bio Solutions Inc.

142 West 57th Street
11th Floor
New York, NY 10019
United States
(646) 828-8258
https://ibs.inc

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 51

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Harry Simeonidis	President & CEO	310.79k	N/A	1967
Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law	Chief Financial Officer	274.43k	N/A	1962
Ms. Victoria Gavrilenko	Operations Manager	45k	N/A	1983
Mr. Alex Arzeno	VP of Investor Relations	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Corporate governance

Intelligent Bio Solutions Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.